Strong Buy
Average AnalystN/A
Top AnalystBearish
Stock Target AdvisorN/A
Average UserUSD 1.32
-0.07 (-4.69)%
USD 0.02B
0.05M
USD 6.00(+354.55%)
Based on the bioAffinity Technologies, Inc. stock forecast from 1 analysts, the average analyst target price for bioAffinity Technologies, Inc. is USD 6.00 over the next 12 months. bioAffinity Technologies, Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of bioAffinity Technologies, Inc. is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, bioAffinity Technologies, Inc.’s stock price was USD 1.32. bioAffinity Technologies, Inc.’s stock price has changed by -12.00% over the past week, -26.67% over the past month and -23.70% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers median on a price to book value basis.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.